CDRE Cadre Holdings, Inc.
Orthopedic, Prosthetic & Surgical Appliances & Supplies · NYSE · SEC CIK 1860543 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY18.3%
TTM net income YoY-9.4%
TTM EPS YoY-18.0%
Revenue 3-yr CAGR15.0%
Net income 3-yr CAGR4.9%
Margins
Gross margin42.0%
Operating margin10.7%
Net margin5.6%
FCF margin10.4%
EBITDA margin13.9%
Returns
ROE11.6%
ROA4.8%
ROIC (approx.)9.0%
Asset turnover0.85x
Leverage & solvency
Liabilities / assets60.2%
Debt / equity1.01x
Current ratio2.35x
Interest coverage—
Cash quality & payout
Operating cash flow / net income2.16x
Accruals ratio-5.6%
Payout ratio40.6%
Capex / revenue1.7%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $202.88M | $207.13M | $155.43M | $167.22M | $155.87M | $157.11M | $130.11M | $175.98M |
| Cost of revenue | $114.78M | $119.99M | $95.26M | $94.60M | $89.24M | $92.86M | $73.97M | $98.80M |
| Gross profit | $88.09M | $87.14M | $60.17M | $72.62M | $66.62M | $64.25M | $56.13M | $77.19M |
| SG&A expense | $58.88M | $63.22M | $48.83M | $50.62M | $45.63M | $45.13M | $41.75M | $45.05M |
| Operating income | $28.35M | $22.46M | $7.49M | $20.44M | $18.67M | $14.69M | $13.55M | $29.40M |
| Interest expense | — | — | — | — | — | $3.59M | $2.23M | $2.19M |
| Pretax income | $23.93M | $16.91M | $2.83M | $17.66M | $14.84M | $17.21M | $12.61M | $22.72M |
| Income tax | $7.95M | $5.51M | $856,000 | $5.93M | $3.90M | $5.00M | $3.36M | $9.73M |
| Net income | $15.98M | $11.41M | $1.98M | $11.74M | $10.94M | $12.21M | $9.25M | $12.98M |
| EBITDA | $34.79M | $28.63M | $13.22M | $25.16M | $24.05M | $19.36M | $17.41M | $33.50M |
| EPS (basic) | 0.37 | 0.27 | 0.05 | — | 0.27 | 0.30 | 0.23 | — |
| EPS (diluted) | 0.37 | 0.26 | 0.05 | — | 0.27 | 0.30 | 0.23 | — |
| Dividends declared per share | 0.10 | 0.10 | 0.10 | 0.10 | 0.10 | 0.10 | 0.10 | -0.17 |
| Weighted avg. shares (diluted) | 43.47M | 43.39M | 43.36M | — | 40.98M | 40.94M | 40.98M | — |
| Banking | ||||||||
| Deposits | — | — | — | $32.46M | — | — | — | $10.00M |
| Balance sheet | ||||||||
| Cash & equivalents | $63.92M | $53.98M | $41.27M | $122.90M | $150.88M | $137.47M | $133.43M | $124.93M |
| Receivables | $127.08M | $128.44M | $111.29M | $110.61M | $99.43M | $108.13M | $82.90M | $93.52M |
| Inventory | $126.67M | $129.12M | $130.99M | $100.26M | $112.20M | $109.60M | $91.79M | $82.35M |
| Current assets | $356.10M | $348.12M | $318.76M | $365.87M | $386.22M | $381.02M | $332.51M | $327.57M |
| PP&E, net | $125.00M | $125.44M | $124.11M | $78.82M | $77.59M | $81.91M | $45.08M | $45.24M |
| Goodwill | $233.73M | $233.91M | $231.22M | $181.41M | $179.17M | $174.46M | $148.61M | $148.16M |
| Intangibles | $170.90M | $174.15M | $173.32M | $114.98M | $117.91M | $126.41M | $105.88M | $107.54M |
| Total assets | $922.69M | $917.30M | $879.74M | $770.03M | $792.05M | $794.44M | $656.29M | $652.71M |
| Current liabilities | $151.45M | $162.42M | $141.17M | $104.50M | $106.04M | $106.07M | $93.67M | $94.12M |
| Short-term debt | $20.01M | $20.01M | $16.26M | $16.27M | $16.27M | $16.27M | $11.38M | $11.38M |
| Long-term debt | $349.47M | $354.32M | $349.57M | $290.99M | $294.97M | $298.88M | $209.13M | $211.83M |
| Total debt | $369.48M | $374.33M | $365.83M | $307.25M | $311.24M | $315.15M | $220.51M | $223.21M |
| Total liabilities | $555.91M | $570.50M | $543.62M | $452.23M | $451.68M | $461.98M | $338.73M | $341.20M |
| Shareholders' equity | $366.78M | $346.80M | $336.12M | $317.80M | $340.37M | $332.46M | $317.56M | $311.51M |
| Net debt | $305.56M | $320.35M | $324.56M | $184.35M | $160.36M | $177.68M | $87.08M | $98.27M |
| Shares outstanding | 42.92M | 42.82M | 42.80M | 42.16M | 40.68M | 40.66M | 40.66M | 40.61M |
| Cash flow statement | ||||||||
| Operating cash flow | $22.93M | $22.13M | $22.52M | $21.25M | $22.48M | $2.59M | $17.39M | $23.71M |
| Capital expenditure | $3.07M | $3.45M | $2.68M | $3.27M | $849,000 | $1.42M | $1.31M | $1.29M |
| Free cash flow | $19.86M | $18.68M | $19.84M | $17.98M | $21.63M | $1.16M | $16.08M | $22.42M |
| Investing cash flow | -$4.64M | -$13.75M | -$156.23M | -$3.20M | -$849,000 | -$91.01M | -$1.31M | -$1.31M |
| Financing cash flow | -$7.16M | $4.39M | $52.89M | -$43.77M | -$7.59M | $90.75M | -$7.81M | $9.84M |
| Depreciation & amortization | $6.44M | $6.17M | $5.73M | $4.72M | $5.38M | $4.68M | $3.86M | $4.09M |
| Stock-based compensation | $5.07M | $2.96M | $1.93M | $5.40M | $2.45M | $2.42M | $1.97M | $2.11M |
| Dividends paid | $4.28M | $4.28M | $4.28M | $3.86M | $3.86M | $3.86M | $3.86M | $3.55M |
Free plan shows the latest 8 periods; Pro shows all 27 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.